- Our Story
- Mission & Values
- Corporate Fact Sheet
- Social Responsibility
- Ethical Research & Development
- Conscientious Collaboration
Coleman N. Lannum
Coleman N. Lannum is Vice President of Investor Relations of Covidien plc, a position he has held since joining Covidien in September 2006.
In this position, Mr. Lannum is responsible for developing Covidien’s relationship with shareholders and institutional investors and plays a key role in shaping corporate strategy.
Mr. Lannum joined Covidien with almost 20 years of experience in the professional money management business. He previously served as a senior health care investment analyst for American Express Asset Management, which he joined in 2005.
Prior to American Express, he was Senior Portfolio Manager, Senior Analyst and Vice President at Putnam Investments. Mr. Lannum co-managed the Putnam Classic Equity Fund and the Putnam Health Sciences Trust, which represented just under $10 Billion in assets. In addition, he was also the Healthcare specialist for Putnam’s Large Cap Value group, with over $40 billion in assets under management. Prior to becoming a Portfolio Manager at Putnam, he was the senior analyst in charge of Medical Technology and Biotechnology and managed the health care sleeve of the Putnam Research Fund.
Earlier in his career, Mr. Lannum led the investor relations effort at Mallinckrodt, Inc., overseeing strategic communications with the investment community as the company evolved from a specialty chemicals company to an emerging healthcare company.
Before joining Mallinckrodt in 1994, Mr. Lannum was Senior Investment Officer and healthcare analyst with Boatmen’s Trust Company (now part of Columbia asset management) and also was an equity analyst at Edward Jones and Company.
A Chartered Financial Analyst, Mr. Lannum holds a Bachelor’s degree in Business Administration from Washington University’s Olin School of Business (Missouri), and a Master’s degree in Business Administration from Texas A&M University.